EVALUASI PENGGUNAAN OBAT ANTITUBERKULOSIS PADA PASIEN TUBERKULOSIS PARU DI INSTALASI RAWAT INAP BLU RSUP PROF. DR. R. D. KANDOU MANADO PERIODE JANUARI – DESEMBER 2010

Abstract

This study aims to examine the patterns of the use of antituberculosis drugs (OAT) and to evaluate the
suitability of the use of OAT based on the Guidelines for Tuberculosis Control 2009 by Ministry of
Health RI, in hospitalized patients with pulmonary tuberculosis in BLU RSUP Prof. Dr. R. D. Kandou
Manado period January to December 2010. This study is a descriptive survey research and data
collection carried out retrospectively. Data was analyzed with descriptive analysis. The results
showed patients with category 1 of an intensive phase is given the alloy HRZE or 4FDC and
continoum phase patients is given the alloy HR. Category 2 patients, the 2-month intensive phase is
given the alloy HRZES and for category 2 patients at 1-month intensive phase is given the alloy
HRZE. A total of 97.7% of patients prescribed a single drug dosage OAT (generic) and 2.3% of
patients prescribed OAT FDC. Based on the suitability of the selection of alloys OAT, for the
treatment of category 1 have met the suitability of 94.7% and category 2 is 66.7%, compliance with
the standards of the Guidelines for Tuberculosis Control 2009 by Ministry of Health RI.
Keywords: OAT, pulmonary tuberculosis, hospitalized patients